




Searching News Database: aptamer
HSMN NewsFeed - 18 Sep 2014
NOXXON Pharma Expands Management Team by Appointing Don Munoz as Chief Financial Officer
NOXXON Pharma Expands Management Team by Appointing Don Munoz as Chief Financial Officer
HSMN NewsFeed - 23 Sep 2010
BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
HSMN NewsFeed - 11 Jun 2008
NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company
NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company
HSMN NewsFeed - 22 Apr 2008
Archemix' ARC1779 Granted Orphan Designation for the Treatment of TTP, a Life-Threatening Blood Disorder
Archemix' ARC1779 Granted Orphan Designation for the Treatment of TTP, a Life-Threatening Blood Disorder
HSMN NewsFeed - 13 Aug 2007
Ophthotech Raises $36 Million; In-Licenses Two Compounds for Macular Degeneration
Ophthotech Raises $36 Million; In-Licenses Two Compounds for Macular Degeneration
HSMN NewsFeed - 27 Jul 2007
OSI Pharmaceuticals Announces Agreement to Divest Anti-Platelet Derived Growth Factor (PDGF) Program
OSI Pharmaceuticals Announces Agreement to Divest Anti-Platelet Derived Growth Factor (PDGF) Program
HSMN NewsFeed - 11 Jun 2007
Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
HSMN NewsFeed - 17 Jan 2007
Archemix and Merck KGaA to Collaborate on Aptamer-Based Cancer Therapeutics
Archemix and Merck KGaA to Collaborate on Aptamer-Based Cancer Therapeutics
HSMN NewsFeed - 3 Oct 2006
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer
HSMN NewsFeed - 6 Jul 2006
Nuvelo Announces Publication of Phase 2 Alfimeprase Study Results in Central Venous Catheter Occlusion
Nuvelo Announces Publication of Phase 2 Alfimeprase Study Results in Central Venous Catheter Occlusion
HSMN NewsFeed - 29 Jun 2006
Nuvelo Expands Depth in Manufacturing and Development With Key Additions to Management Team
Nuvelo Expands Depth in Manufacturing and Development With Key Additions to Management Team
HSMN NewsFeed - 31 May 2006
Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
Additional items found! 34

Members Archive contains
34 additional stories matching:
aptamer
(Password required)
aptamer
(Password required)